were compared at incubation times of 16 to 48 h on 22 patient specimens. Only the Du Pont antibody showed 100% sensitivity and specificity and no nonspecific reactions.
Patient specimens, urine samples, or bronchoalveolar lavages, from which CMV had been isolated, were also used. Two urine samples had been frozen at -70°C; all other specimens were stored at 4°C until use. Urine titers ranged from 100 to 104 FNID5dmi.
The following monoclonal antibodies to CMV were used in the comparison fluorescence studies: (i) chromatographically purified mouse monoclonal anti-CMV early-nuclearprotein antibody immunoglobulin G2A (Du Pont) at a 1:20 dilution, the same antibody used in the original study by Gleaves (2) method is highly specific and sensitive. The virus titer was an important factor for detectability, since the high-titer stock virus preparations were detected by all reagents in almost every case. Some urine specimens with high virus titers were detected by reagents other than the Du Pont reagent. The Du Pont indirect reagent worked best with the shorter incubation time, while other reagents that yielded positive results favored the longer incubation time. The shorter incubation time yielded faster results and less chance of contamination. Of the direct and indirect reagents and methods (three each) compared in this study, only the indirect reagent by Du Pont gave acceptable results. There has been speculation that the direct reagents do not perform well because, in the process of conjugation, the monoclonal antibodies may be functionally damaged. Unpublished data from our laboratory showed that a direct CMV conjugate that is no longer available worked almost as well as the Du Pont indirect antibody. It has also been reported that a direct conjugate works well in a study of 188 specimens (1). Several companies have monoclonal antibodies to CMV under development which were not available for use in our comparative study. This study shows that the testing of these new reagents should be performed not only on high-titer stock CMV but also on clinical specimens to determine the ability of the reagents to detect low-titer CMV. In conclusion, the Du Pont indirect monoclonal anti-CMV antibody is best for the rapid detection of CMV.
